Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1463
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1) ; day:1 ; month:3 ; year:2022 ; pages:1
Journal of neural transmission ; (1.3.2022), 1
- Creator
-
Wilson, Heather
Pagano, Gennaro
Yousaf, Tayyabah
Polychronis, Sotirios
Micco, Rosa De
Giordano, Beniamino
Niccolini, Flavia
Politis, Marios
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00702-022-02476-7
- URN
-
urn:nbn:de:101:1-2022052908063112739010
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wilson, Heather
- Pagano, Gennaro
- Yousaf, Tayyabah
- Polychronis, Sotirios
- Micco, Rosa De
- Giordano, Beniamino
- Niccolini, Flavia
- Politis, Marios
- SpringerLink (Online service)
Other Objects (12)
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Polypharmacy Associated with Cognitive Decline in Newly Diagnosed Parkinson’s Disease: A Cross-Sectional Study
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease